SLC5A4 and Hypoglycemia: Although the relative effect size was similar (∼13%), we highlight the critical role of SGLT3 in mediating an enhanced glucose-lowering effect in a diabetic phenotype, without inducing hypoglycemia in normoglycemic animals.